Literature DB >> 16208765

Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis.

Antti Alitalo1, Taru Meri, Pär Comstedt, Luke Jeffery, Johanna Tornberg, Tomas Strandin, Hilkka Lankinen, Sven Bergström, Marina Cinco, Santosh R Vuppala, Darrin R Akins, Seppo Meri.   

Abstract

The Lyme disease-pathogen Borrelia burgdorferi binds the complement inhibitor factor H (FH) to its outer surface protein E- (OspE) and BbA68-families of lipoproteins. In earlier studies, only serum-resistant strains of the genospecies B. burgdorferi sensu stricto or B. afzelii, but not serum-sensitive B. garinii strains, have been shown to bind FH. Since B. garinii often causes neuroborreliosis in man, we have readdressed the interactions of B. garinii with FH. B. garinii 50/97 strain did not express FH-binding proteins. By transforming the B. garinii 50/97 strain with an OspE-encoding gene from complement-resistant B. burgdorferi (ospE-297), its resistance to serum killing could be increased. OspE genes were detected and cloned from the B. garinii BITS, Pistoia and 40/97 strains by PCR and sequencing. The deduced amino acid sequences differed in an N-terminal lysine-rich FH-binding region from OspE sequences of resistant strains. Recombinant B. garinii BITS OspE protein was found to have a considerably lower FH-binding activity than the B. burgdorferi sensu stricto 297 OspE protein P21 (P21-297). Unlike bacteria that had been kept in culture for a long time, neurovirulent B. garinii strains from neuroborreliosis patients were found to express approximately 27-kDa FH-binding proteins. These were not recognized by polyclonal anti-OspE or anti-BbA68 antibodies. We conclude that B. garinii strains carry ospE genes but have a decreased expression of OspE proteins and a reduced ability to bind FH, especially when grown for prolonged periods in vitro. Recently isolated neuroinvasive B. garinii strains, however, can express FH-binding proteins, which may contribute to the virulence of neuroborreliosis-causing B. garinii strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208765     DOI: 10.1002/eji.200526354

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H.

Authors:  T Meri; S J Cutler; A M Blom; S Meri; T S Jokiranta
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

3.  Structural basis for complement evasion by Lyme disease pathogen Borrelia burgdorferi.

Authors:  Arnab Bhattacharjee; Jesper S Oeemig; Robert Kolodziejczyk; Taru Meri; Tommi Kajander; Markus J Lehtinen; Hideo Iwaï; T Sakari Jokiranta; Adrian Goldman
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

4.  Toward a better understanding of European lyme neuroborreliosis.

Authors:  Gary P Wormser; John J Halperin
Journal:  Clin Infect Dis       Date:  2013-05-10       Impact factor: 9.079

5.  Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.

Authors:  Klemen Strle; Elise E Drouin; Shiqian Shen; Joseph El Khoury; Gail McHugh; Eva Ruzic-Sabljic; Franc Strle; Allen C Steere
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

6.  Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Authors:  Corinna Siegel; Teresia Hallström; Christine Skerka; Hannes Eberhardt; Barbara Uzonyi; Tobias Beckhaus; Michael Karas; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

7.  Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.

Authors:  Elizabeth A Rogers; Shane V Abdunnur; John V McDowell; Richard T Marconi
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

8.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

Review 9.  Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle.

Authors:  Tomasz Bykowski; Michael E Woodman; Anne E Cooley; Catherine A Brissette; Reinhard Wallich; Volker Brade; Peter Kraiczy; Brian Stevenson
Journal:  Int J Med Microbiol       Date:  2007-12-31       Impact factor: 3.473

Review 10.  Complement regulator-acquiring surface proteins of Borrelia burgdorferi: Structure, function and regulation of gene expression.

Authors:  Peter Kraiczy; Brian Stevenson
Journal:  Ticks Tick Borne Dis       Date:  2012-11-10       Impact factor: 3.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.